Metagenomi
Metagenomi is a biotech company based in Emeryville, California, developing curative therapeutics through advanced genome editing tools and AI-driven metagenomics.
Company Overview
Metagenomi is a biotechnology company headquartered in Emeryville, California. The company specializes in developing potentially curative therapeutics using a metagenomics-powered genome editing toolbox. Their expertise includes the utilization of artificial intelligence and metagenomics to discover novel cellular systems, which are fundamental in creating curative genetic medicines.
Genome Editing Tools
Metagenomi offers a comprehensive toolbox of next-generation gene editing tools. These include programmable nucleases, base editors, and RNA- and DNA-mediated integration systems. The company focuses on using these advanced tools to develop therapies aimed at combating devastating diseases through a stepwise approach.
Discovery Platform
The Discovery Platform at Metagenomi leverages artificial intelligence to sift through billions of novel proteins from the natural world, identifying those that can be used for genome editing. The platform engages in high-throughput screening to rapidly pinpoint efficient, specific, and targetable genome editing tools, potentially accelerating the discovery and development of new genetic medicines.
Metagenomics Approach
Metagenomi is known for venturing into less-explored natural environments to uncover undiscovered genetic material. This genetic material is then sequenced and engineered into genetic medicines. Their approach combines metagenomics and AI to create innovative genome editing solutions, setting them apart in the biotech industry.
Industry Recognition
In 2023, Metagenomi was recognized by Fast Company as one of the most innovative biotech companies. This recognition underscores the company's contributions to advancing genome editing technologies and developing potentially curative genetic medicines.